P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD

J. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda Lowes, Lindsay N. Alfano, A. Martín Gómez, Sarah Lewis, Vineeta Malik, Kim Shontz, K. Flanigan, John R. Kean, Hugh D. Allen, Christopher Shilling, Peter Sazani, Jihad B. Saoud, Edward M. Kaye

Neuromuscular Disorders

August 28, 2013

10.1016/j.nmd.2013.06.581

Cited by 1

Abstract

Related Papers

No related papers found

Powered by citation graph analysis